ArticleMethods in molecular biology (Clifton, N.J.)2027
Purification of Nascent, Chromatin-Associated RNA Enriched for RNA Modifications.
Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RNAs that are being synthesized and remain tethered to chromatin during transcription are key participants in co-transcriptional gene regulation. They contribute to essential processes such as splicing, transcription elongation, and chromatin structure shaping. Co- and post-transcriptional RNA modifications have emerged as critical regulators of RNA metabolism and may modulate the function of chromatin-associated RNAs, including their interactions with chromatin. Here, we describe a method to isolate nascent, chromatin-associated RNA enriched for specific RNA modifications, using a combination of metabolic labeling, cell fractionation, and immunoprecipitation. This approach involves labeling of newly transcribed RNA with nucleotide analogs, followed by subcellular fractionation to enrich for chromatin-bound RNA species. Subsequently, immunoprecipitation with RNA modification-specific antibodies is used to selectively purify RNA bearing specific epitranscriptomic marks. We detail each component of the protocol, which can be adapted to various mammalian cell types and experimental conditions. The nature of this workflow enables investigation of RNA modifications on nascent, chromatin-associated transcripts under physiological or perturbed conditions, including various stimuli, genetic mutants, or disease-relevant cell lines.
Indexed as
Identifiers
42911484What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.